We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+9.95%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$148B
AUM Growth
+$13.7B
Cap. Flow
+$2.5B
Cap. Flow %
1.69%
Top 10 Hldgs %
25.2%
Holding
4,104
New
267
Increased
1,933
Reduced
1,554
Closed
192

Sector Composition

Rank Sector Weight
1 Technology 16.03%
2 Financials 9.11%
3 Healthcare 8.03%
4 Industrials 6.97%
5 Consumer Discretionary 6.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VMBS icon
326
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.6B
$70.1M 0.05%
1,537,946
-46,597
-3% -$2.12M
JPST icon
327
JPMorgan Ultra-Short Income ETF
JPST
$40.6B
$70M 0.05%
1,387,419
+154,712
+13% +$7.79M
FAST icon
328
Fastenal
FAST
$59.8B
$69.9M 0.05%
1,811,000
+10,658
+0.6% +$377K
SRE icon
329
Sempra
SRE
$55.1B
$69.8M 0.05%
971,728
+60,997
+7% +$4.37M
AMP icon
330
Ameriprise Financial
AMP
$49.2B
$69.6M 0.05%
158,681
-13,436
-8% -$5.38M
MNST icon
331
Monster Beverage
MNST
$89.6B
$69.5M 0.05%
2,345,842
+66,180
+3% +$1.9M
MLM icon
332
Martin Marietta Materials
MLM
$33B
$69.4M 0.05%
113,018
+9,571
+9% +$5.22M
AWK icon
333
American Water Works
AWK
$26.9B
$69.2M 0.05%
566,506
+27,622
+5% +$3.4M
CASY icon
334
Casey's General Stores
CASY
$31.6B
$68.8M 0.05%
216,200
+16,193
+8% +$4.73M
MO icon
335
Altria Group
MO
$109B
$68.7M 0.05%
1,575,191
+21,741
+1% +$901K
SHEL icon
336
Shell
SHEL
$248B
$68.7M 0.05%
1,024,623
+34,735
+4% +$2.23M
REGN icon
337
Regeneron Pharmaceuticals
REGN
$83.2B
$68.7M 0.05%
71,341
+4,342
+6% +$4.13M
TRP icon
338
TC Energy
TRP
$66B
$68.4M 0.05%
1,702,045
+95,092
+6% +$3.75M
AMLP icon
339
Alerian MLP ETF
AMLP
$13.3B
$68.2M 0.05%
1,437,498
+131,689
+10% +$5.92M
BTI icon
340
British American Tobacco
BTI
$123B
$68.2M 0.05%
2,236,759
-185,108
-8% -$5.57M
AFL icon
341
Aflac
AFL
$61.1B
$68M 0.05%
792,420
+53,463
+7% +$4.38M
CDNS icon
342
Cadence Design Systems
CDNS
$91.4B
$67.9M 0.05%
218,215
-5,296
-2% -$1.57M
WCN
343
Waste Connections
WCN
$41.8B
$67.8M 0.05%
394,313
-6,399
-2% -$1.03M
CP icon
344
Canadian Pacific Kansas City
CP
$79.6B
$67.7M 0.05%
767,465
+38,575
+5% +$3.24M
MRVL icon
345
Marvell Technology
MRVL
$187B
$67.4M 0.05%
951,090
+30,458
+3% +$2.09M
CRL icon
346
Charles River Laboratories
CRL
$13.2B
$67.3M 0.05%
248,348
+4,660
+2% +$1.11M
CSX icon
347
CSX Corp
CSX
$92.8B
$67.1M 0.05%
1,810,990
+128,941
+8% +$4.71M
COR icon
348
Cencora
COR
$62B
$66M 0.04%
271,690
-23,588
-8% -$5.42M
TEL icon
349
TE Connectivity
TEL
$62B
$65.8M 0.04%
453,373
-202,501
-31% -$28.4M
LII icon
350
Lennox International
LII
$14.6B
$65.7M 0.04%
134,337
+8,526
+7% +$3.88M

Similar funds

Raymond James & Associates's Q1 2024 Portfolio in Review

As of Q1 2024, Raymond James & Associates held 4,104 positions worth $148B, up 10% from $134B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Raymond James & Associates's Q1 2024 filing shows 267 new, 1,933 increased, 1,554 reduced and 192 closed positions. Its largest new stake was Veralto: 431,115 shares worth $38.2M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $233M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q1 2024 buy was Veralto: 431,115 shares worth $38.2M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q1 2024, an estimated $292M increase.
  • Raymond James & Associates's biggest Q1 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $233M.
  • Raymond James & Associates fully exited Splunk Inc in Q1 2024, selling an estimated $14.6M.
  • Raymond James & Associates's ten largest holdings make up 25% of its $148B portfolio in Q1 2024.
  • Raymond James & Associates opened 267 new positions and closed 192 in Q1 2024.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $148B.

Based on Raymond James & Associates's 13F filing for Q1 2024, filed 22 Apr 2024.